Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex

The Rat Brain in Stereotaxic Coordinates

1982 • 53,055 citations

The rat brain in stereotaxic coordinates

1983 • 28,962 citations

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1996 • 1,143 citations

Depression: Perspectives from Affective Neuroscience

2002 • 1,118 citations

The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia

1999 • 1,012 citations

Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

2003 • 891 citations

DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION

1996 • 764 citations

Serotonin receptors : their key role in drugs to treat schizophrenia

2003 • 759 citations

Depression: a case of neuronal life and death?

2004 • 609 citations

Binding of antipsychotic drugs to human brain receptors

2000 • 594 citations

A Novel Augmentation Strategy for Treating Resistant Major Depression

2001 • 513 citations

5‐HT_2A and D₂ receptor blockade increases cortical DA release via 5‐HT_1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine release

2001 • 491 citations

Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

2001 • 485 citations

Central monoamines and their role in major depression

2004 • 477 citations

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.

1999 • 427 citations

Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic Terminals

1990 • 407 citations

Treatment options for refractory depression.

1999 • 317 citations

Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?

1994 • 317 citations

Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex

2002 • 316 citations

A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence.

1990 • 261 citations

Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression

1999 • 249 citations

Role of Serotonin in Depression^a

1990 • 239 citations

Synergistic Effects of Olanzapine and Other Antipsychotic Agents in Combination with Fluoxetine on Norepinephrine and Dopamine Release in Rat Prefrontal Cortex

2000 • 231 citations

Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.

1997 • 228 citations

Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects.

1990 • 220 citations

Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release

1998 • 202 citations

Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism

2002 • 196 citations

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

1998 • 190 citations

Enhanced Cortical Dopamine Output and Antipsychotic-like Effects of Raclopride by α ₂ Adrenoceptor Blockade

1999 • 171 citations

R-fluoxetine Increases Extracellular DA, NE, As Well As 5-HT in Rat Prefrontal Cortex and Hypothalamus An in vivo Microdialysis and Receptor Binding Study

2002 • 154 citations

Augmentation and combination strategies in treatment-resistant depression.

2001 • 144 citations

In vivo biogenic amine efflux in medial prefiontal cortex with imipramine, fluoxetine, and fluvoxamine

1994 • 137 citations

S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

2001 • 136 citations

Treatment strategies for chronic and refractory obsessive-compulsive disorder.

1997 • 136 citations

Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization.

1996 • 134 citations

A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression

1999 • 124 citations

Electrophysiological evidence for a functional interaction between 5‐HT_1A and 5‐HT_2A receptors in the rat medial prefrontal cortex: An lontophoretic study

1994 • 119 citations

Evidence that Extracellular Concentrations of Dopamine Are Regulated by Noradrenergic Neurons in the Frontal Cortex of Rats

1994 • 115 citations

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain

1996 • 112 citations

The Effectiveness of Olanzapine, Risperidone, Quetiapine, and Ziprasidone as Augmentation Agents in Treatment-Resistant Major Depressive Disorder

2004 • 108 citations

What Role Do Atypical Antipsychotic Drugs Have in Treatment-Resistant Depression?

2002 • 108 citations

Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of α2-adrenergic receptors underlie its actions

1999 • 104 citations

Effect of 5-HT1A Receptor Antagonists on Citalopram-induced Increase in Extracellular Serotonin in the Frontal Cortex, Striatum and Dorsal Hippocampus

1997 • 102 citations

TREATMENT ALGORITHMS IN TREATMENT-RESISTANT DEPRESSION

1996 • 97 citations

Effects of Serotonin (5-Hydroxytryptamine, 5-HT) Reuptake Inhibition Plus 5-HT_2A Receptor Antagonism on the Firing Activity of Norepinephrine Neurons

2002 • 95 citations

Fluoxetine Increases Extracellular Dopamine in the Prefrontal Cortex by a Mechanism Not Dependent on Serotonin

1999 • 86 citations

Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens

1998 • 86 citations

R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.

1999 • 76 citations

An Open Pilot Study Combining Risperidone and a Selective Serotonin Reuptake Inhibitor as Initial Antidepressant Therapy

2002 • 74 citations

Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex

2003 • 69 citations

Risperidone Dose-Dependently Increases Extracellular Concentrations of Serotonin in the Rat Frontal Cortex: Role of α2-Adrenoceptor Antagonism

1997 • 69 citations

Measuring Antidepressant Prescribing Practice in a Health Care System Using Administrative Data: Implications for Quality Measurement and Improvement

2000 • 69 citations

Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex

1999 • 64 citations

Brain region and dose effects of an olanzapine/fluoxetine combination on extracellular monoamine concentrations in the rat

2003 • 62 citations

Treatment of major depression: is improvement enough?

1999 • 61 citations

Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: Secondary analyses of a double-blind, placebo-controlled, randomized clinical trial

2004 • 61 citations

Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine

2004 • 57 citations

DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release

2001 • 55 citations

Influence of 5-HT1A receptors on central noradrenergic activity: microdialysis studies using (±)-MDL 73005EF and its enantiomers

1999 • 49 citations

Selective reduction by isolation rearing of 5‐HT_1A receptor‐mediated dopamine release in vivo in the frontal cortex of mice

2002 • 43 citations

Depression and antidepressant therapy: Receptor dynamics

1990 • 43 citations

New approaches to the treatment of depression.

1996 • 40 citations

Histamine regulates food intake through modulating noradrenaline release in the para-ventricular nucleus

1999 • 38 citations

Biochemical profile of YM992, a novel selective serotonin reuptake inhibitor with 5-HT2A receptor antagonistic activity

1996 • 37 citations

The use of antidepressants in novel combination therapies.

2003 • 33 citations

Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men

1995 • 30 citations

Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex

2004 • 30 citations

Are Atypical Antipsychotic Drugs also Atypical Antidepressants?

2001 • 27 citations

Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex

2000 • 27 citations

Augmentation of milnacipran by risperidone in treatment for major depression

2004 • 16 citations

Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex

2000 • 15 citations

Antidepressants.

1997 • 10 citations

Reboxetine modulates norepinephrine efflux in the frontal cortex of the freely moving rat: the involvement of α2 and 5-HT1A receptors

2003 • 8 citations

Economic impact of olanzapine plus fluoxetine combination therapy among patients treated for depression: a pilot study.

2003 • 5 citations